'The chicken or the egg?' dilemma strikes back for the controlling mechanism in chordoma(#)
- PMID: 22952146
- DOI: 10.1002/path.4102
'The chicken or the egg?' dilemma strikes back for the controlling mechanism in chordoma(#)
Abstract
Chordoma is a rare malignant tumour of bone showing notochordal differentiation with characteristic expression of the transcription factor brachyury (T). Next to giving insight into its differentiation spectrum, the expression of T can be used as an adjunct diagnostic tool. The expression of brachyury in chordoma is necessary to maintain cell proliferation in chordoma cell lines, indicating that in chordoma it might be a master regulator of oncogenesis. Identification and mapping of the full gene regulatory network in a recent work in The Journal of Pathology by Nelson and colleagues not only shed light on involved pathways but also indicated pathways for targeted therapy, including brachyury itself.
Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Comment on
-
An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma.J Pathol. 2012 Nov;228(3):274-85. doi: 10.1002/path.4082. Epub 2012 Sep 26. J Pathol. 2012. PMID: 22847733 Free PMC article.
Similar articles
-
An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma.J Pathol. 2012 Nov;228(3):274-85. doi: 10.1002/path.4082. Epub 2012 Sep 26. J Pathol. 2012. PMID: 22847733 Free PMC article.
-
Brachyury and chordoma: the chondroid-chordoid dilemma resolved?J Pathol. 2006 Jun;209(2):143-6. doi: 10.1002/path.1987. J Pathol. 2006. PMID: 16604512
-
The driver landscape of sporadic chordoma.Nat Commun. 2017 Oct 12;8(1):890. doi: 10.1038/s41467-017-01026-0. Nat Commun. 2017. PMID: 29026114 Free PMC article.
-
Novel therapeutic targets in chordoma.Expert Opin Ther Targets. 2012 Nov;16(11):1139-43. doi: 10.1517/14728222.2012.714772. Epub 2012 Aug 4. Expert Opin Ther Targets. 2012. PMID: 22860993 Review.
-
Notochordal Tumors: An Update on Molecular Pathology with Therapeutic Implications.Surg Pathol Clin. 2017 Sep;10(3):637-656. doi: 10.1016/j.path.2017.04.008. Epub 2017 Jun 29. Surg Pathol Clin. 2017. PMID: 28797506 Review.
Cited by
-
FAS/FASL are dysregulated in chordoma and their loss-of-function impairs zebrafish notochord formation.Oncotarget. 2014 Jul 30;5(14):5712-24. doi: 10.18632/oncotarget.2145. Oncotarget. 2014. PMID: 25071022 Free PMC article.
-
Multidisciplinary management of clival chordomas; long-term clinical outcome in a single-institution consecutive series.Acta Neurochir (Wien). 2017 Oct;159(10):1857-1868. doi: 10.1007/s00701-017-3266-1. Epub 2017 Jul 22. Acta Neurochir (Wien). 2017. PMID: 28735379 Free PMC article.
-
Molecular profiling of chordoma.Int J Oncol. 2014 Apr;44(4):1041-55. doi: 10.3892/ijo.2014.2268. Epub 2014 Jan 21. Int J Oncol. 2014. PMID: 24452533 Free PMC article.
-
[Novel molecular aspects of chordomas].Pathologe. 2014 Nov;35 Suppl 2:237-41. doi: 10.1007/s00292-014-1986-z. Pathologe. 2014. PMID: 25394972 German.
-
Active receptor tyrosine kinases, but not Brachyury, are sufficient to trigger chordoma in zebrafish.Dis Model Mech. 2019 Jul 16;12(7):dmm039545. doi: 10.1242/dmm.039545. Dis Model Mech. 2019. PMID: 31221659 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical